Key Study Information:

  • Treatment Area:

    Parkinson's Disease

  • Study Aim:

    To advance our understanding of Parkinson’s Disease and accelerate the development of advanced therapies to improve outcomes for patients.

  • Sponsor/Owner:

    Queen Mary University of London

  • Goal:

    Ongoing patient recruitment of patient's diagnosed with Parkinson's Disease.

See Study Details

Key Study Information:

  • Treatment Area:

    Multiple Sclerosis

  • Study Aim:

    To discover whether the genes that contribute to MS risk are the same or different for people of non-European ancestry, with a focus on people from African & South Asian backgrounds.

  • Sponsor/Owner:

    Queen Mary University London

  • Goal:

    400 patients and has a study period of 10 years

See Study Details

Key Study Information:

  • Treatment Area:

    COPD

  • Study Aim:

    A study to discover whether a new investigational medication (Tozorakimab) could help reduce the number of exacerbations for people with COPD.

  • Sponsor/Owner:

    AstraZeneca

  • Goal:

    30+ patients that have symptomatic COPD, with a history of COPD exacerbations.

See Study Details

Key Study Information:

  • Treatment Area:

    RSV

  • Study Aim:

    To understand how strongly babies can be protected from serious illness due to RSV infection (respiratory syncytial virus) by giving them a single antibody dose.

  • Sponsor/Owner:

    LabCorp/SANOFI

  • Goal:

    Aims to recruit 12,000 babies <1 year old

See Study Details